Reuters logo
BRIEF-Interpace Diagnostics Group launches multi-site study to provide further evidence of clinical utility of ThyGenx/ThyramiR tests
December 13, 2016 / 1:18 PM / 9 months ago

BRIEF-Interpace Diagnostics Group launches multi-site study to provide further evidence of clinical utility of ThyGenx/ThyramiR tests

Dec 13 (Reuters) - Interpace Diagnostics Group Inc :

* Interpace Diagnostics Group - has launched multi-site study to provide further evidence of clinical utility of thygenx/thyramir tests Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below